S&P 500 cuts losses as Nvidia climbs ahead of results
Grail Inc. (GRAL) Chief Financial Officer Aaron Freidin sold 8,000 shares of common stock on July 15, 2025, at a price of $38.93, for a total transaction value of $311,440. The transaction comes as GRAL shares have declined 17% over the past week, though the stock maintains an impressive 106% gain over the past six months, according to InvestingPro data. Following the transaction, Freidin directly owns 286,020 shares of Grail Inc.
The sale was executed under a Rule 10b5-1 trading plan adopted on March 13, 2025.
In other recent news, GRAIL, Inc. reported positive top-line results from its PATHFINDER 2 study, which evaluated the Galleri multi-cancer early detection test in over 25,000 participants. The study showed that adding Galleri to standard cancer screening significantly increased cancer detection rates, with no serious safety concerns reported. The company plans to submit these results to the FDA as part of its premarket approval application. Meanwhile, Canaccord Genuity raised GRAIL’s stock price target to $43, citing the company’s growth potential in the multi-cancer early detection market, despite a slightly higher-than-expected cash burn in the first quarter. GRAIL’s revenue from the Galleri test increased by 24% year-over-year, and the company maintained its full-year 2025 guidance. In contrast, a report by Ningi Research labeled GRAIL as a short, highlighting regulatory challenges and questioning the commercial viability of the Galleri test. The report raised doubts about the test’s efficacy and reimbursement prospects, suggesting potential financial distress for the company. Additionally, Morgan Stanley (NYSE:MS) increased its price target for GRAIL to $38, noting the significant long-term potential of the Galleri test but maintaining an Equalweight rating due to regulatory and reimbursement risks. Lastly, GRAIL’s stockholders recently elected a director and ratified Ernst & Young LLP as the company’s independent auditor for the fiscal year 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.